Công ty Cổ phần Dược phẩm OPC - Thương hiệu Dược phẩm uy tín hàng đầu với hơn 46 năm trong lĩnh vực sản xuất và kinh doanh thuốc từ dược liệu. Kim Tiền Thảo, Dầu Khuynh Diệp, HoAstex,... là các sản phẩm đã gắn liền với nhiều thế hệ người dân Việt Nam.

Outcomes-based contracts (OBCs), a type of risk-sharing arrangement (RSA), have emerged as a promising avenue for payers to engage with pharmaceutical manufacturers to share risk and improve patient access to medicines via evaluation of real-world outcomes.

OBCs connect reimbursement to the value of a pharmaceutical product and are an avenue to share risk and align incentives. Performance-Linked – Reimbursement level of drug is linked to the measure of clinical or other outcomes

Jul 1, 2019 · OBC is a contract and sales model that enables pharmaceutical manufacturers to take a more holistic approach, including use of performance-based contracts that include risk-sharing arrangements in an effort to place and maintain certain drugs in the formularies of payers.

Oct 30, 2019 · Two emerging value-based models for pharmaceuticals are outcome-based contracting (OBC) and indication-based management (IBM). In the OBC model, pharmaceutical manufacturers and payors enter into a risk-sharing agreement where drug reimbursements are based on outcomes in actual patient populations.

Mar 17, 2017 · Health insurers and other healthcare purchasers are increasingly reluctant to pay for drugs that don’t work. That has led payers to experiment with outcomes-based contracts (OBCs) that hold pharmaceutical companies responsible for …

As the United States health care system shifts from traditional volume-based payments to value-based payments, outcomes-based contracts (OBCs) are gaining popularity among payers and manufacturers as a mechanism for the shift toward value.

Olympia Pharmaceuticals is a 503A compounding pharmacy and FDA 503B Outsourcing Facility specializing in TriMix injections for ED, weight management, IV therapy and more for men and women.

Leveraging innovative ADC enabling technologies and key products, OBI Pharma has embraced new and flexible business models to work with local and global biotech firms and pharmaceutical companies. Through collaborations and licensing agreements, this strategy […]

Objective: To understand the experiences, perceptions, and needs of payers and manufacturers related to OBCs. Methods: The Academy of Managed Care Pharmacy (AMCP) and Xcenda conducted an online survey with AMCP payer and manufacturer members.